Clinical Trials List
2022-09-01 - 2024-07-15
Phase III
Recruiting2
Terminated4
ICD-10K52.2
Allergic and dietetic gastroenteritis and colitis
ICD-10K52.89
Other specified noninfective gastroenteritis and colitis
ICD-10R19.7
Diarrhea, unspecified
ICD-9787.91
Diarrhea
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yu-Chao Lin 無
- Chia-Hsiang Li 無
- Chih-Yen Tu 無
- 陳鴻仁 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- YEN-TING LIN Division of General Internal Medicine
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- 徐偉勛 醫學研究部
- Chong-Jen Yu Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉建廷 Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 陳秉聰 Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ta-Chung Chao Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 施穎銘 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
- 林慶雄 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 林明泰 Division of Thoracic Medicine
- 陳正雄 Division of Thoracic Medicine
- 林俊維 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
- 張竣期 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
256 participants